price must come into it , they either receive 110% of face value now or 90% of face value in nine months (through 11c shares at a premium to current).
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025